Rachel E. Haurwitz
Co-Founder, CEO, President & DirectorDr. Rachel E. Haurwitz, Ph.D., has been the President and Chief Executive Officer at Caribou Biosciences, Inc. since October 2011. She served as independent Director at Seer, Inc. since December 21, 2023 until July 08, 2024. She served as Director at Seer, Inc. since 2023 until December 21, 2023 and served as its Independent Director since November 08, 2021 until 2023. Dr. Haurwitz co-founded Caribou Biosciences, Inc. in 2011. Dr. Haurwitz is a Co-Founder of Intellia Therapeutics Inc. She serves as a Director at Caribou Biosciences, Inc. She served as a Director of Intellia Therapeutics Inc. from July 2014 to November 1, 2016 and served as its Member of Scientific Advisor Board. She is an inventor on several patents and patent applications covering multiple CRISPR-derived technologies and she has co-authored scientific papers in high impact journals characterizing CRISPR-Cas systems. She has a research background in CRISPR biology and in 2014, she was named by Forbes to the “30 Under 30” list in Science and Healthcare. In 2018, the Association for Women in Science recognized Rachel with the annual Next Generation Award. She serves on the Board of Directors of the Biotechnology Organization (BIO) since February 2020. She earned an A.B. in Biological Sciences from Harvard College and received a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley.
Positions
- Company NameCaribou Biosciences, Inc.Stock CodeCRBUPositionCo-Founder, CEO, President & DirectorColleagues
- RERachel E. HaurwitzCo-Founder, CEO, President & Director
- ALAndrew L. GuggenhimeIndependent Chairman
- SRSriram RyaliChief Financial Officer
- BGBarbara G. McClungChief Legal Officer & Corporate Secretary
- JAJennifer A. DoudnaCo-founder & Member of Scientific Advisory Board
- RFRyan FischesserInterim Principal Accounting Officer & Controller
- NSNatalie SacksIndependent Director
- SNScott N. BraunsteinIndependent Director
- Company NameIntellia Therapeutics, Inc.Stock CodeNTLAPositionCo-FounderColleagues
- JMJohn M. LeonardPresident, CEO & Director
- FAFranciscus A. G. M. VerwielIndependent Chairman of the Board
- EJEdward J. DulacExecutive VP, CFO & Treasurer
- BSBirgit SchultesExecutive VP & Chief Scientific Officer
- JEJames E. BastaExecutive VP, General Counsel & Corporate Secretary
- JAJennifer A. DoudnaFounder & Member of Scientific Advisor Board
- DJDerrick J. RossiFounder & Member of Scientific Advisor Board
- RBRodolphe BarrangouFounder & Member of Scientific Advisor Board
